Terrance P. Coyne - EVP & CFO at Royalty Pharma plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Evp & Cfo
Issuer Symbol
RPRX on Nasdaq
All Insider Reports
All Insider Reports

Terrance P. Coyne - trading volume in the past year for Royalty Pharma plc

Holdings reported by Terrance P. Coyne for Royalty Pharma plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
LP interests in RPI US Partners 2019, LP 483,942 $160,426,773 $331.50 06 Aug 2025 By TPC RP, LLC Class A Ordinary Shares 4,839,420
LP interests in RPI US Partners 2019, LP 117,526 $38,959,869 $331.50 06 Aug 2025 By TPC RP 2021, LLC Class A Ordinary Shares 1,175,260
Class A Ordinary Shares 460,828 $17,703,030 $38.42 02 Jan 2026 By TPC RP 2021, LLC
LP interests in RPI US Partners 2019, LP 43,350 $14,370,525 $331.50 08 Aug 2025 By TPC ICAI, LLC Class A Ordinary Shares 433,500
Class A Ordinary Shares 39,760 $1,527,408 $38.42 02 Jan 2026 TPC RP EPA1 LLC
Class A Ordinary Shares 24,170 $933,928 $38.64 02 Jan 2026 By Spouse's IRA
Class A Ordinary Shares 23,270 $899,152 $38.64 02 Jan 2026 By IRA
Class A Ordinary Shares 1,500 $57,960 $38.64 02 Jan 2026 Direct
Class A Ordinary Shares 1,450 $56,028 $38.64 02 Jan 2026 By Spouse
Class E Ordinary Shares 1,807,277 16 May 2025 Indirect Class A Ordinary Shares

Transactions reported by Terrance P. Coyne for Royalty Pharma plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.